UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial

Gynecologic oncology, 2017-08, Vol.146 (2), p.279-284

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of MammaPrint and BluePrint on early breast cancer treatment decisions: WSG PRIMe study results

Breast (Edinburgh), 2017-03, Vol.32, p.S107-S107

2017

Link zum Volltext

Verfügbarkeit prüfen

1869 Disease characteristics of subgroup patients treated with everolimus + exemestane for <12 months, ≥12 to <18months, and ≥18 months - Results of the 3rd interim analysis of the non-interventional trial BRAWO

European journal of cancer (1990), 2015-09, Vol.51, p.S288-S289

2015

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study

Breast (Edinburgh), 2019-06, Vol.45, p.22-28

2019

Link zum Volltext

Verfügbarkeit prüfen

Electrochemotherapy in the treatment of cutaneous malignancy; outcomes and subgroup analysis from the cumulative results from the pan- European InspECT Database for 1478 lesions in 691 patients (2008-2018)

European journal of surgical oncology, 2019-02, Vol.45 (2), p.e19-e19

2019

Link zum Volltext

Verfügbarkeit prüfen

P255 - Impact of MammaPrint and BluePrint on early breast cancer treatment decisions: WSG PRIMe study results

Breast (Edinburgh), 2017-03, Vol.32, p.S107-S107

2017

Link zum Volltext

Verfügbarkeit prüfen

158. Pathological Complete Response is not the Best Prognostic Factor in Patients with Breast Cancer Treated by Preoperative Chemotherapy

Breast cancer research and treatment, 2003-05, Vol.79 (2), p.279-279

2003

Link zum Volltext

Verfügbarkeit prüfen

Low neurotoxicity of chemotherapy with Carboplatin/Docetaxel for reccurent epithelial ovarian cancer

European journal of cancer (1990), 1999-09, Vol.35, p.S244-S244

1999

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant cisplatin and treosulfan chemotherapy in epithelial ovarian cancer stage I–III after complete surgical resection

European journal of cancer (1990), 1997-09, Vol.33, p.S121-S121

1997

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Bacterial Infections of the Female Urinary Tract by Immunization of the Patients

The Journal of urology, 1988-09, Vol.140 (3), p.681-682

1988

Link zum Volltext

Verfügbarkeit prüfen

Surgical procedure can explain varying influence of menstrual cycle on prognosis of premenopausal breast cancer patients

Breast (Edinburgh), 1995-03, Vol.4 (1), p.29-32

1995

Link zum Volltext

Verfügbarkeit prüfen

Treatment of bacterial infections of the female urinary tract by immunization of the patients

Urologia internationalis, 1987, Vol.42 (5), p.338

1987

Link zum Volltext

Verfügbarkeit prüfen

Akardius oder "Twin-Reversed-Arterial-Perfusion"-Sequenz

Der Pathologe, 2000-08, Vol.21 (4), p.308-314

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Breast
(4)
European Journal Of Cancer
(4)
Annals Of Oncology
(1)
Breast Cancer Research And Treatment
(1)
Der Pathologe
(1)
European Journal Of Surgical Oncology
(1)
Gynecologic Oncology
(1)
The Journal Of Urology
(1)
Urologia Internationalis
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial

Impact of MammaPrint and BluePrint on early breast cancer treatment decisions: WSG PRIMe study results

1869 Disease characteristics of subgroup patients treated with everolimus + exemestane for <12 months, ≥12 to <18months, and ≥18 months - Results of the 3rd interim analysis of the non-interventional trial BRAWO

Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019)

Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2− early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2− trial

Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study

Electrochemotherapy in the treatment of cutaneous malignancy; outcomes and subgroup analysis from the cumulative results from the pan- European InspECT Database for 1478 lesions in 691 patients (2008-2018)

P255 - Impact of MammaPrint and BluePrint on early breast cancer treatment decisions: WSG PRIMe study results

158. Pathological Complete Response is not the Best Prognostic Factor in Patients with Breast Cancer Treated by Preoperative Chemotherapy

Low neurotoxicity of chemotherapy with Carboplatin/Docetaxel for reccurent epithelial ovarian cancer

Adjuvant cisplatin and treosulfan chemotherapy in epithelial ovarian cancer stage I–III after complete surgical resection

Treatment of Bacterial Infections of the Female Urinary Tract by Immunization of the Patients

Surgical procedure can explain varying influence of menstrual cycle on prognosis of premenopausal breast cancer patients

Treatment of bacterial infections of the female urinary tract by immunization of the patients

Akardius oder "Twin-Reversed-Arterial-Perfusion"-Sequenz

Suchergebnisse filtern